Cargando…
Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer
The aim of this study was to evaluate the clinical outcome of CyberKnife stereotactic body radiotherapy (SBRT) for patients with stage I non-small cell lung cancer (NSCLC). Fifty patients with peripheral stage I NSCLC who refused surgery or were medically inoperable were treated with 48–60 Gy (media...
Autores principales: | Shen, Ze-Tian, Wu, Xin-Hu, Li, Bing, Zhu, Xi-Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312559/ https://www.ncbi.nlm.nih.gov/pubmed/25638468 http://dx.doi.org/10.1007/s12032-015-0506-1 |
Ejemplares similares
-
Thymic Carcinoma Treated by CyberKnife Stereotactic Body Radiotherapy
por: Harada, Yuko, et al.
Publicado: (2017) -
CyberKnife Stereotactic Radiosurgery for Cholangiocarcinoma
por: Harada, Yuko, et al.
Publicado: (2017) -
CyberKnife Stereotactic Radiotherapy in Secondary Vasoproliferative Tumor of the Retina
por: İpek, Şefik Can, et al.
Publicado: (2021) -
CyberKnife Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Gynecological Cancers
por: Kataria, Tejinder, et al.
Publicado: (2021) -
CyberKnife stereotactic radiotherapy for treatment of primary intracranial tumors in dogs
por: Carter, Gabrielle L., et al.
Publicado: (2021)